Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
Preferences
to previous section to next section

close this bookGuidelines for the Treatment of Malaria (WHO; 2006; 266 pages) View the PDF document
View the documentGlossary
View the documentAbbreviations
open this folder and view contents1. Introduction
View the document2. The clinical disease
open this folder and view contents3. Treatment objectives
close this folder4. Diagnosis of malaria
View the document4.1 Clinical diagnosis
View the document4.2 Parasitological diagnosis
View the document4.3 Where malaria transmission is low to moderate and/or unstable
View the document4.4 In stable high-transmission settings
View the document4.5 Malaria parasite species identification
View the document4.6 In epidemics and complex emergencies
open this folder and view contents5. Resistance to antimalarial medicines9
open this folder and view contents6. Antimalarial treatment policy
open this folder and view contents7. Treatment of uncomplicated P. Falciparum malaria10
open this folder and view contents8. Treatment of severe falciparum malaria14
open this folder and view contents9. Treatment of malaria caused by P. vivax, P. ovale or P. malariae19
View the document10. Mixed malaria infections
open this folder and view contents11. Complex emergencies and epidemics
open this folder and view contentsAnnexes
 

4.5 Malaria parasite species identification

In areas where two or more species of malaria parasites are common, only a parasitological method will permit a species diagnosis. Where mono-infection with P. vivax is common and microscopy is not available, it is recommended that a combination RDT which contains a pan-malarial antigen is used. Alternatively, RDTs specific for falciparum malaria may be used, and treatment for vivax malaria given only to cases with a negative test result but a high clinical suspicion of malaria. Where P. vivax, P. malariae or P. ovale occur almost always as a co-infection with P . falciparum, an RDT detecting P. falciparum alone is sufficient. Anti-relapse treatment with primaquine should only be given to cases with confirmed diagnosis of vivax malaria.

to previous section to next section

Please provide your feedback   English  |  French  |  Spanish